PT  - JOURNAL ARTICLE
AU  - Su Wang
AU  - Victor-Felix Mautner
AU  - Jan M. Friedman
AU  - Manraj K. S. Heran
TI  - Alterations in Brain Morphology by MRI in Adults with NF1
AID  - 10.1101/2019.12.19.19015255
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 2019.12.19.19015255
4099  - http://medrxiv.org/content/early/2019/12/21/2019.12.19.19015255.short
4100  - http://medrxiv.org/content/early/2019/12/21/2019.12.19.19015255.full
AB  - Objective To explore and characterize alterations in brain morphology by MRI in adults with neurofibromatosis 1 (NF1).Methods MRI measurements of 29 intracranial structures were obtained for 389 adults with NF1 and 112 age- and sex-matched unaffected control subjects. A subset of NF1 patients (n = 70) was also assessed for clinical severity of NF1 features and neurological problems and received psychometric testing for attention deficiencies and IQ. Brain morphological measurements were compared between NF1 and control subjects, and correlation analyses were performed between principal components of the intracranial measurements and clinical and psychometric features.Results Four of nine corpus callosum measurements were significantly greater in adults with NF1 than in sex- and age-matched controls. All seven brainstem measurements were significantly greater in adults with NF1 than in controls. No robust correlations were observed between the size of these structures and clinical or neuropsychometric assessments.Conclusions Our findings are consistent with the hypothesis that dysregulation of brain myelin production is an important manifestation of NF1 in adults.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe are grateful to the Bundesverband Neurofibromatose organization for funding this project.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymous data is available for appropriate research purposes through V.F. Mautner, MD.